Hualan Biological Engineering Inc (Hualan Biological) is a biopharmaceutical company that carries out research, development and commercialization of blood products, vaccines, recombinant proteins and other biological products. The company's product portfolio includes hepatitis b human immunoglobulin, human albumin, intravenous human immunoglobulin (pH4), human immunoglobulin, tetanus human immunoglobulin, and freeze-dried human fibrin glue. It also provides products such as zymogen complex, human coagulation factor VIII, human fibrinogen, and rabies immune globulin. Hualan Biological offers blood products under the brand Hualan. The company's products are used in the treatment of hypoalbuminemia, distress syndrome, immunodeficiency disease, bacterial and viral infections, hepatitis B, and hemophilia A. It operates manufacturing facilities in China. Hualan Biological is headquartered in Xinxiang, Henan, China.
Headquarters
China
Address
No.A1, Hualan Avenue, Xinxiang, Henan, 453003
Website
english.hualanbio.com
Telephone
86 373 3559989
No of Employees
2,927
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
002007 (SHE)
Revenue (2020)
$687.8M
-11.7%
(2020 vs 2019)
EPS
XXX
Net Income (2020)
XXX
-19.5%
(2020 vs 2019)
Market Cap*
$5.5B
Net Profit Margin (2020)
XXX
-8.8%
(2020 vs 2019)
* As of and is in US$
Access premium data and analytics for Hualan Biological Engineering Inc
Products and Services
| Products | Brands |
|---|---|
| Hepatitis B Human Immunoglobulin | Hualan |
| Human Albumin | |
| Intravenous Human Immunoglobulin (pH4) | |
| XXX | |
| XXX | |
| XXX |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2020 | New Product Approvals | In June, the company's recombinant exendin-4-Fc fusion protein injection was approved for clinical use in the treatment of diabetes. |
| 2020 | Financing Agreements | In March, Hualan Biological and other companies invested US$291.9 million in Hualan Biological Engineering. |
| 1992 | Incorporation/Establishment | The company was founded. |
Competitor Comparison
| Key Parameters | Hualan Biological Engineering Inc | Sinovac Biotech Ltd | Chongqing Zhifei Biological Products Co Ltd | Shanghai RAAS Blood Products Co Ltd | Henan Lingrui Pharmaceutical Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Xinxiang | Beijing | Chongqing | Shanghai | Xinyang |
| State/Province | Henan | Beijing | Chongqing | Shanghai | Henan |
| No. of Employees | 2,927 | 4,281 | 4,800 | 2,966 | 2,500 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Ankang | Chairman | Executive Board | 2007 | 73 |
| Fan Bei | Managing Director | Executive Board | 2022 | 50 |
| Zhang Baoxian | Director; Deputy General Manager | Executive Board | 2022 | 51 |
| Xie Junmin | Chief Financial Officer; Secretary | Senior Management | 2013 | 55 |
| Liu Jun | Deputy General Manager | Senior Management | 2022 | 46 |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
| Non Dignissim Eros | Proin vel | Convallis | 2022 | XX |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer